vimarsana.com

Latest Breaking News On - Chimerix company profile - Page 1 : vimarsana.com

Chimerix (NASDAQ:CMRX) Issues Earnings Results

Chimerix (NASDAQ:CMRX) Issues Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Chimerix-company-profile
Chimerix-inc
Get-free-report
Chimerix-daily

Short Interest in Chimerix, Inc. (NASDAQ:CMRX) Rises By 6.5%

Short Interest in Chimerix, Inc. (NASDAQ:CMRX) Rises By 6.5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Chimerix-inc
Vance-wealth-inc
Chimerix-company-profile
Nasdaq
York-mellon-corp
Get-free-report
Fire-capital
New-york-mellon-corp
Vestal-point-capital
Chimerix-daily

Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update

Chimerix, Inc. (NASDAQ:CMRX) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
York-mellon-corp
Chimerix-inc
Vance-wealth-inc
Chimerix-company-profile
Get-free-report
New-york-mellon-corp
Fire-capital
Chimerix-daily

Chimerix (NASDAQ:CMRX) Stock Price Crosses Below 200 Day Moving Average of $1.17

Chimerix, Inc. (NASDAQ:CMRX – Get Free Report)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.17 and traded as low as $0.97. Chimerix shares last traded at $0.98, with a volume of 403,193 shares changing hands. Analysts Set […]

Switzerland
Swiss
Nasdaq
Dimensional-fund-advisors
Chimerix-company-profile
Swiss-national-bank
Jpmorgan-chase-co
Chimerix-inc
Metlife-investment-management
Get-free-report
National-bank

Chimerix (NASDAQ:CMRX) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Robert W. Baird began coverage on shares of Chimerix in a research report on Monday, May 22nd. They […]

Switzerland
Swiss
Robertw-baird
Metlife-investment-management
Chimerix-inc
Swiss-national-bank
Dimensional-fund-advisors
Jpmorgan-chase-co
Chimerix-company-profile
Free-report
Moderate-buy

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.